Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 4
2020 1
2021 3
2022 3
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Targeting Immunometabolism in Glioblastoma.
Mohan AA, Tomaszewski WH, Haskell-Mendoza AP, Hotchkiss KM, Singh K, Reedy JL, Fecci PE, Sampson JH, Khasraw M. Mohan AA, et al. Among authors: singh k. Front Oncol. 2021 Jun 16;11:696402. doi: 10.3389/fonc.2021.696402. eCollection 2021. Front Oncol. 2021. PMID: 34222022 Free PMC article. Review.
Correcting the drug development paradigm for glioblastoma requires serial tissue sampling.
Singh K, Hotchkiss KM, Parney IF, De Groot J, Sahebjam S, Sanai N, Platten M, Galanis E, Lim M, Wen PY, Minniti G, Colman H, Cloughesy TF, Mehta MP, Geurts M, Arrillaga-Romany I, Desjardins A, Tanner K, Short S, Arons D, Duke E, Wick W, Bagley SJ, Ashley DM, Kumthekar P, Verhaak R, Chalmers AJ, Patel AP, Watts C, Fecci PE, Batchelor TT, Weller M, Vogelbaum MA, Preusser M, Berger MS, Khasraw M. Singh K, et al. Nat Med. 2023 Oct;29(10):2402-2405. doi: 10.1038/s41591-023-02464-8. Nat Med. 2023. PMID: 37488293 No abstract available.
Novel Immunotherapeutic Approaches for the Treatment of Glioblastoma.
Zaidi SE, Moelker E, Singh K, Mohan A, Salgado MA, Essibayi MA, Hotchkiss K, Shen S, Lee W, Sampson J, Khasraw M. Zaidi SE, et al. Among authors: singh k. BioDrugs. 2023 Jul;37(4):489-503. doi: 10.1007/s40259-023-00598-2. Epub 2023 May 31. BioDrugs. 2023. PMID: 37256535 Review.
Enhancing T Cell Chemotaxis and Infiltration in Glioblastoma.
Singh K, Hotchkiss KM, Patel KK, Wilkinson DS, Mohan AA, Cook SL, Sampson JH. Singh K, et al. Cancers (Basel). 2021 Oct 26;13(21):5367. doi: 10.3390/cancers13215367. Cancers (Basel). 2021. PMID: 34771532 Free PMC article. Review.
Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma.
Singh K, Batich KA, Wen PY, Tan AC, Bagley SJ, Lim M, Platten M, Colman H, Ashley DM, Chang SM, Rahman R, Galanis E, Mansouri A, Puduvalli VK, Reardon DA, Sahebjam S, Sampson JH, Simes J, Berry DA, Zadeh G, Cloughesy TF, Mehta MP, Piantadosi S, Weller M, Heimberger AB, Khasraw M. Singh K, et al. Clin Cancer Res. 2022 Feb 15;28(4):585-593. doi: 10.1158/1078-0432.CCR-21-2681. Clin Cancer Res. 2022. PMID: 34561270 Free PMC article. Review.
An unusual case of a grade I meningioma with perineural spread.
Fadelalla M, Kanodia AK, Brunton J, Singh K, Torgersen A, Sammler E, Smith C, Mowle D, White P, Hossain-Ibrahim K. Fadelalla M, et al. Among authors: singh k. Br J Neurosurg. 2023 Aug;37(4):637-640. doi: 10.1080/02688697.2018.1530730. Epub 2018 Nov 19. Br J Neurosurg. 2023. PMID: 30450991
13 results